Yi-Ching Wang

Personal profile

Education

1993 PhD,Department of Genetics, Michigan State University

Experience

1995~1999 Associate Professor, Institute of Toxicology, Chung Shan Medical Univ., Taichung, Taiwan
1999~2006 Professor, Department of Life Science, National Taiwan Normal Univ., Taipei, Taiwan
2006~2015 Distinguished Professor, Department of Pharmacology, National Cheng Kung University, Tainan, Taiwan
2015~now Chair Professor, Department of Pharmacology & Institute of Basic Medical Science & Institute of Clinical Medical Science, National Cheng Kung University, Tainan, Taiwan

Research Interests

Molecular cancer biology
Cancer epigenetics
Transcription deregulation in cancer
Vesicle trafficking in tumor microenvironment
Anticancer drug development

Fingerprint Dive into the research topics where Yi-Ching Wang is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

56 Similar Profiles

Lung Neoplasms Medicine & Life Sciences

Neoplasms Medicine & Life Sciences

Non-Small Cell Lung Carcinoma Medicine & Life Sciences

Methylation Medicine & Life Sciences

Neoplasm Metastasis Medicine & Life Sciences

Genes Medicine & Life Sciences

Histone Deacetylase Inhibitors Medicine & Life Sciences

Lung Medicine & Life Sciences

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Projects 2006 2020

1 Active
31 Finished

探討ZNF322A致癌蛋白參與肺癌形成與轉移的分子機制

Wang, Y.

19-08-01 → 20-07-31

Project: Research project

浸潤免疫細胞之Rab37與癌細胞之WDR4協同調控肺腫瘤微環境中逃避免疫攻擊的機制(2/3)

Wang, Y.

18-08-01 → 19-07-31

Project: Research project

探討ZNF322A致癌蛋白參與肺癌形成與轉移的分子機制

Wang, Y.

18-08-01 → 19-07-31

Project: Research project

浸潤免疫細胞之Rab37與癌細胞之WDR4協同調控肺腫瘤微環境中逃避免疫攻擊的機制(1/3)

Wang, Y.

17-08-01 → 18-07-31

Project: Research project

以肺癌為模式探討Rab37在囊泡運輸及抑癌機制中之角色-Rab37蛋白磷酸化及其效應蛋白在囊泡運輸及抑癌機制之角色(3/3)

Wang, Y.

17-08-01 → 18-07-31

Project: Research project

Research Output 1991 2019

3716 Citations
36 h-Index
109 Article
2 Review article
2 Patent
1 Chapter
2 More
- 1 Conference contribution
- 1 Editorial

1 Citation (Scopus)

LncRNA NORAD is repressed by the YAP pathway and suppresses lung and breast cancer metastasis by sequestering S100P

Tan, B. S., Yang, M. C., Singh, S., Chou, Y. C., Chen, H. Y., Wang, M. Y., Wang, Y-C. & Chen, R. H., 2019 Jul 11, In : Oncogene. 38, 28, p. 5612-5626 15 p.

Research output: Contribution to journal › Article

Lung Neoplasms

Long Noncoding RNA

Breast Neoplasms

Neoplasm Metastasis

Mi-2 Nucleosome Remodeling and Deacetylase Complex

1 Citation (Scopus)

SOX17 overexpression sensitizes chemoradiation response in esophageal cancer by transcriptional down-regulation of DNA repair and damage response genes 11 Medical and Health Sciences 1112 Oncology and Carcinogenesis

Kuo, I. Y., Huang, Y. L., Lin, C. Y., Lin, C. H., Chang, W-L., Lai, W-W. & Wang, Y-C., 2019 Feb 18, In : Journal of biomedical science. 26, 1, 510.

Research output: Contribution to journal › Article

Open Access

Oncology

Esophageal Neoplasms

DNA Repair

DNA Damage

Carcinogenesis

Oncogenic zinc finger protein ZNF322A promotes stem cell-like properties in lung cancer through transcriptional suppression of c-Myc expression

Jen, J., Liu, C., Chen, Y., Wu, L., Shieh, Y., Lai, W. & Wang, Y., 2018, In : Cell Death and Differentiation.

Research output: Contribution to journal › Article

6 Citations (Scopus)

Rab37 in lung cancer mediates exocytosis of soluble ST2 and thus skews macrophages toward tumor-suppressing phenotype

Tzeng, H. T., Su, C. C., Chang, C. P., Lai, W. W., Su, W. C. & Wang, Y-C., 2018 Oct 1, In : International Journal of Cancer. 143, 7, p. 1753-1763 11 p.

Research output: Contribution to journal › Article

Exocytosis

Lung Neoplasms

Macrophages

Phenotype

Neoplasms

1 Citation (Scopus)